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Introduction
Racial inequities in cardiovascular disease in New 
Zealand
Worldwide, cardiovascular disease (CVD) is the topmost cause 
of death and equally one of the most preventable causes of 
mortality. Coincident with rapid economic development across 
the world CVD is a considerable burden on healthcare resources 
in both the developed and rapidly developing countries [1]. 
CVD is the leading cause of death in Aotearoa/New Zealand, 
that annually accounts for 40% of all deaths, with proportionally 
more deaths per 100 000 occurring in Māori [2]. Diminished 
life expectancy is one example of racial inequity in healthcare 
between Māori and Pākehā (the non-indigenous population). 
Ischaemic heart disease (IHD), a major cause of CVD deaths, 
accounts for 40.2% of Māori deaths from this condition in those 
aged less than 65 years, compared to 10.5% of Pākehā deaths 
[3].
The literature is replete with studies pertaining to ethnic 
inequities in healthcare. A thorny subject that has been described 
for decades and yet has few remedial solutions. The pattern of 
ethnic inequities in healthcare is a global phenomenon that is 
not confined to any specific race or culture. The socio-economic, 
cultural and environmental conditions in which people live 
greatly influence their chances of being healthy.
“Indeed factors such as poverty, social exclusion and 
discrimination, poor housing, unhealthy early childhood 
conditions and low occupational status are important 
determinants of most diseases, deaths and health inequities 
between and within countries” [4].
The main determinants of health have been conceptualised as a 
complex, layered spectrum of factors generated by the macro-
policy environment such as neo-liberal economic growth 
strategies that have widened the gap between the rich and 
the poor [5]. Suggest four interdependent factors that can be 
grouped together as spheres of influence that impact health and 
which may form the basis of a health policy intervention (Figure 
1). The main influences that affect health can be described as; 
promoting health; protecting health; and threatening health. 
Dahlgren and Whitehead warn that all too often strategies 
are aimed at correcting a single level of influence, whereas 
interventions that address several levels may be more effective 
[5]. Equally evident is that positive actions at one level may be 
offset by negative actions at other levels; e.g. health education 
for young people being nullified by insufficient funds for school 
lunches [5]. Surviving and living a healthy life remain closely 
related to the socioeconomic background of individuals and 
families that are reflected in substantial and ever increasing 
social inequities in health [6]. However, very few countries 
have developed strategies for the integration of equity-
oriented health policies into economic and social legislation. 
The reduction of inequities in the health status between less 
privileged socioeconomic groups and their more privileged 
counterparts, Dahlgren and Whitehead suggest should be key to 
all international, national and local health policies [6].
For some, inequity in healthcare is tantamount to racism [7-
10]. In New Zealand, Harris states that racism is an important 
determinant of health and a cause of ethnic inequities [11]. 
Embedded in the socio-economic, cultural and environmental 
influences of New Zealand health is ethnic identity. Māori 
are tangata whenua, the indigenous people of Aotearoa/New 
Zealand, who collectively have a lower level of educational, 
occupational and income status, and have poorer health than 
Pākehā, [non-Māori] [12]. Howden-Chapman suggest that such 
ethnic inequities arise from other, pervasive characteristics of 
New Zealand society that result in poor health in the Māori 
and Pacific peoples, e.g. income inequity [13]. Population-
based policies, directed to the whole population, rather than 
targeted social and health measures, are (paradoxically) likely 
acial Inequities in Cardiovascular Disease in New 
Zealand 
Warren Miner-Williams
Research Officer, Person Centred Research, School of Clinical Sciences, Faculty of Health and Environmental Sciences, Auckland University 
of Technology, 90 Akoranga Drive, Northcote, Auckland, 0627, New Zealand
ABSTRACT
The literature is replete with studies pertaining to ethnic 
inequities in healthcare. A thorny subject that has been 
described for decades and yet has few remedial solutions. 
The pattern of ethnic inequities in healthcare is a global 
phenomenon that is not confined to any specific race or 
culture. Worldwide, cardiovascular disease (CVD) is the 
topmost cause of death and a substantial burden on healthcare 
resources. In New Zealand CVD is the leading cause of death, 
accounting for 40% of all deaths annually. Diminished life 
expectancy is one example of racial inequity in healthcare 
between Māori and Pākehā (the non-indigenous population). 
This review attempts to clarify the muddy waters of 175 years 
of post-colonial healthcare inequity in New Zealand and in 
particular the causes of inequity in the incidence of CVD and 
mortality in Māori. Such dialogue will hopefully stimulate 
discussion among policy makers and clinicians to redress the 
ethnic inequities in healthcare.
Keywords: Inequity in healthcare; Treaty of Waitangi; 
Institutional racism; Interpersonal racism; Internalized racism; 
Indigenous people
Miner-Williams W24
to provide the greatest benefit for low income groups and those 
with higher risk factors [13]. However, Howden-Chapman 
et al. warn that targeting ‘the poor’ will fail to minimise the 
overall social variations in health, may stigmatise poor people 
and even accentuate health inequities. They suggest that a range 
of population wide, mutually reinforcing redistributive policies 
are required to redress the imbalance in income, education, 
employment, housing and health services [13]. Since their 
editorial 16 years ago little has changed in New Zealand; indeed 
the inequity between the rich and the poor is greater today than 
in 2000 [14].
Race is a social construct not a biological reality typically used in 
a mechanical and uncritical manner as a proxy for immeasurable 
biological, socioeconomic and/or sociocultural factors [7-9]. 
Jones in an invited commentary uses an example that is true to 
Māori and Pākehā in New Zealand today; “Black” in the US is 
over-represented in poverty, but the majority of poor people are 
“White,” as not all Black people are poor [7]. She continues by 
suggesting there is no single Black culture just as there is no 
single White, Hispanic or Asian culture. Genetically, “races” are 
a heterogeneous mixture of geographic stock from many parts 
of the world. Race is a social classification in our race-conscious 
society that conditions many aspects of our lives; which then 
result in profound differences in life opportunities [7]. Whereas 
ethnicity is a reflection of our genetic and cultural heritage, race 
is a measure of identity imposed by society that results in the 
consequent societal constraints associated with that identity. 
The race label assigned by an investigator or volunteered by a 
study participant, Jones suggests, is an “excellent measure of 
exposure to racism” (p. 300) and that it is this aspect of race 
that impacts health and results in race-associated inequities 
that are large, occur throughout a life span and involve many 
different organ systems [7]. Indeed being classified as “White” 
by others has been shown to produce statistically significant 
advantages in health status, irrespective of how a person self-
identifies [15]. Associations of observer-ascribed skin colour 
found a significant gradient in self-rated health by skin colour; 
those with darker skin colour reported poorer health [16]. 
Perreira and Telles concluded that darker skin colouration 
influences self-rated health primarily by an increased exposure 
to class discrimination and low socio-economic status [16]. 
In New Zealand reported that skin colour perceived as white 
was advantageous and health-protective whereas the social-
assignment of being Māori was associated with being at 
risk of differential and discriminatory healthcare [17]. The 
routine documentation of race-associated inequities in health, 
without adequate explanation is not benign as it impedes the 
advancement of scientific knowledge, limits efforts at primary 
prevention, and contributes to ideas of biologic determinism [7].
In 2000, Jones published a 3 level framework for understanding 
racism that included: institutionalized, personally mediated, and 
internalized racism. The concept of the levels that she suggested 
which form the basis of race-related influences in poor health 
outcomes [18] (Figure 2). Institutionalised racism manifests 
itself in differential access to material conditions, (e.g. quality 
education and housing) and access to political influence. 
Personally mediated racism is defined as prejudice and 
discrimination, where prejudice means differential assumptions 
about the abilities, motives and intentions of others according to 
Used with the permission of World Health Organization Regional Office for Europe (2007)
Figure 1: The main determinants of health.
 
Adapted from Jones [18]
Figure 2: The impacts of racism on health
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their race and discrimination means differential actions toward 
others according to their race. Internalized racism is defined as 
acceptance by members of the stigmatized races of negative 
messages about their own abilities and intrinsic worth. It is 
characterized by them not believing in others who look like 
them, and not believing in themselves [18].
The framework devised by can be superimposed upon the 
determinants of health stratified by [5,18]. Racism affects 
health partly because indigenous, minority populations often 
experience less favourable social and economic circumstances 
that allows access to healthcare, (institutionalised racism) 
and partly because of direct psychosocial stress caused by 
personally mediated racism [12,18-20]. Within New Zealand 
and internationally, racism is recognised as an important 
determinant of health [10]. Rata and Zubaran warn that it is 
low socioeconomic status that is the cause of Māori health 
disadvantages not ethnicity [21]. They argue that ethnic 
labelling itself may contribute to negative stereotypes that 
produce racism, which in turn feed the cycles of discrimination 
for ethnic minority groups. They suggest that public healthcare 
policies based on ethnic distinctions should be abandoned in 
favour of “a more tenable approach that recognizes a series of 
other causal factors in social disadvantage” [21]. As the current 
strategies are failing Māori, new initiatives addressing social 
disadvantage and poverty are urgently needed to redress the 
inequities in healthcare.
The health of indigenous people is significantly less than the 
non-indigenous in communities where traditional ways of life, 
environment and livelihoods have been taken over by the worst 
of Western culture e.g. unemployment, poor housing, alcoholism 
and drug use [22]. In Aotearoa/New Zealand from the formation 
of our bicultural society (Māori the indigenous peoples of New 
Zealand and Pākehā non-indigenous people) with the signing of the 
Treaty of Waitangi in 1840, Māori were immediately marginalised. 
The fabric of Māori society; tribal laws, languages, dress, sacred 
ceremonies, rituals, healers and native remedies were suppressed 
by colonial laws and regulations [23]. The dispossession of lands 
and subsequent poverty meant Māori could not compete equally 
within the imposed and dominant western culture to obtain the 
benefits of healthcare, education and employment. For a more 
detailed account of the effect of colonisation of New Zealand 
Māori [24-26].
However, after 176 years it is unhelpful to ascribe current 
inequities to intergenerational psychological trauma caused by 
the impact of a cataclysmic event such as colonisation rhetoric 
such as: “If Māori are getting less, non-Māori are getting more” 
[21,26,27]. If as Jackson suggests, Māori health needs arise as 
a consequence of their indigenous rights being breached, will 
Māori health improve with the reinstatement of such rights? 
Likewise it is naïve to argue that genetic differences are not 
likely to be part of the complex contributory factors for racial 
inequities in New Zealand when, for example, this is clearly 
untrue in the light of research that shows melanocortin-3 
receptor gene variants in Māori are linked to obesity and the 
early onset of type 2 diabetes [28-32]. When seeking the reason 
why health inequity exists in New Zealand today it is not helpful 
to pound the colonisation drum. Modern health inequity requires 
an up-to-date reason as to why Māori have increasing rates of 
CVD when those for Pākehā are decreasing. Rata and Zubaran 
dismiss post-colonial trauma as the root of Māori inequities in 
healthcare and suggest that sociocultural factors, with or without 
an ethnic dimension are more likely the cause of poor outcomes 
in health [21]. When reviewing risk factors why are 40% of 
Māori males and 50% of Māori females, aged 15-64 years, 
continuing to smoke when only 20-21% of Pākehā are? Why 
26% of adult Māori are obese compared to only 18% of Pākehā? 
Using face-to-face interview techniques of 12 500 people. 
Harris et al. [11] reported an association between experiencing 
racial discrimination and socioeconomic deprivation with 
smoking and CVD. Is racial discrimination and socioeconomic 
deprivation the cause of CVD or is CVD the result of exposure 
to risk factors such as smoking and obesity? It is dangerous to 
deflect attention away from the risk factors of CVD and blame 
post-colonial trauma. Likewise it is inappropriate to blame 
racism for the voluntary disregard of CVD risk factors such as 
smoking and obesity; as such factors hold the same proportion 
of risk for all ethnicities. 
Of the many papers that outline health inequities for Māori, very 
few actually outline what Māori require. An exception to this is 
the work of who suggests that in New Zealand the availability 
of care is inversely proportional to the need of the population 
served, where those who need healthcare the most, receive the 
least; the inverse care law first suggested by Curtis suggest 
that three key factors must be addressed in order to invoke 
changes in health equity; a) acknowledging the role of society, 
b) understanding the policy imperatives, and c) exploring the 
clinician’s role. This approach they conclude is consistent with 
the human rights of Māori as tangata whenua, the rights of Māori 
as outlined within the Treaty of Waitangi and New Zealand 
health policy [33,34]. A recurrent theme in the understanding of 
health inequities is the way society distributes health resources, 
of material wealth, housing, education and employment [35]. 
Redressing inequities in power, money and resources should be 
viewed as restorative actions outlined by the Treaty of Waitangi. 
Racial inequities in New Zealand and the increased risk 
of CVD
Although the causes of CVD in minority ethnic groups are not 
completely understood, researchers agree that socioeconomic 
factors are important. Although the classic risk factors associated 
with CVD vary significantly between minority ethnic groups, 
morbidity and mortality are much higher in these groups than in 
Caucasian and Asian populations [36]. The prevention of CVD 
across all ethnic groups relies on; identifying associated risks, 
establishing a safe threshold for such risks and reducing the risk 
factors that may precipitate the disease. The Framingham study 
identified 7 major risk factors; age, sex, blood pressure (BP), 
glucose intolerance, total and high-density cholesterol, smoking 
and left ventricular hypertrophy, that may be used to calculate 
the probability of developing CVD [37]. In addition to these risk 
factors the study by added; apolipoproteins B:A ratio, history of 
hypertension, history of diabetes, diet, inactivity, alcohol use, 
psychosocial stress, and abdominal obesity (which was better 
than BMI as a predictor of myocardial infarction in all ethnic 
groups) [38,39]. Population screening using risk factor analysis 
requires the application of a validated and reliable tool which 
is currently insensitive and not specific enough to apply to 
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ethnically heterogeneous populations [36]. Other risk prediction 
instruments include; PREDICT, FINRISK [40], SCORE [41] 
and ETHRISK [42]. More controversial risk factors have been 
proposed and include; metabolic syndrome, micro albuminuria, 
waist circumference, haemostatic factors, and homo-cysteine 
levels [36]. In New Zealand the national guidelines for the 
prevention of CVD contain an age stratification which make 
screening very cost effective and lists: personal history of 
CVD; age; sex; smoking status; apolipoprotein imbalance; 
hypertension and diabetes as the principal risk factors [43]. 
The guidelines also list other well established determinants of 
CVD risk: atrial fibrillation; obesity; impaired carbohydrate 
metabolism; metabolic syndrome; nutrition and dietary 
patterns; physical inactivity; family history of premature 
CVD; socioeconomic position; depression, social isolation and 
social support. When using the Framingham Risk Equation the 
guidelines list adjustments that include ethnicity. However, 
evaluating the guidelines and appropriateness for screening 
in primary care suggests they would be more effective if they 
incorporated U.S. recommendations on the use of aspirin and 
initial antihypertensive treatment rather than on achieving blood 
pressure targets [44]. 
Higher proportions of Māori live in more deprived areas than 
non-Māori (Figure 3). In 2013, 23.5% of Māori lived in decile 
10 areas compared with 6.8 percent of non-Māori. Only 3.8% 
lived in decile 1 areas as compared to 11.6% of non-Māori).
In New Zealand CVD and diminished life expectancy is one 
example of racial inequity in healthcare between Māori and 
Pākehā (Figure 4). Between 1951 and 2011 the life expectancy 
of Pākehā at birth had increased steadily from 68 to 80 years for 
males and from 72 to 83 years for females. However, during the 
Note: Crude rates and prioritised ethnicity have been used [45]
Figure 3: Neighbourhood deprivation distribution of Māori and non-Māori, 2013.
Data from [45]
Figure 4: Life expectancy at birth for Māori and non-Māori by gender.
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same period the life expectancy of Māori males only increased 
from <56 to 72 years and from 68 to 76 for Māori females [45]. 
The standardised mortality rates for CVD in males and females 
are shown in Table 1. The data show that between 2010 and 2012 
the total CVD mortality rate among Māori was more than twice 
as high as that among non-Māori (RR 2.17, CI 2.08-2.26). In 
2012-14, Māori were more than one-and-a-half times as likely 
as non-Māori to be hospitalised for cardiovascular disease (RR 
1.64, CI 1.61-1.67). The mortality rate for heart failure among 
Māori was more than twice that of non-Māori (RR 2.36, CI 1.76-
3.17), and Māori were about four times as likely as non-Māori 
to be hospitalised for heart failure (RR 4.01, CI 3.83-4.21). 
The inequity was greater for females where the heart failure 
hospitalisation rate among Māori females was nearly four-and-
a-half times that of non-Māori females (RR 4.49, CI 4.16-4.85). 
The mortality rate from rheumatic heart disease among Māori 
was more than five times that of non-Māori (RR 5.23, CI 3.99-
6.87) and the rheumatic heart disease hospitalisation rate for 
Māori was nearly five times that of non-Māori (RR 4.82, CI 
4.23-5.51). The inequity for Māori females for rheumatic heart 
disease hospitalisation was greater than five times that of non-
Māori females (RR 5.30, CI 4.47-6.29) [45]. 
In New Zealand childhood obesity is believed to be the major 
contributing factor in adult obesity and is associated with 
disease conditions such as hypertension, dyslipidaemia, type 
2 diabetes and subsequent CVD. Childhood obesity is more 
prevalent in Māori children (11.8%) compared to those with 
Caucasian heritage (5.5%) [46]. Cardio metabolic health can be 
improved by reducing obesity and increasing cardiorespiratory 
fitness, however, it remains unclear whether fatness or fitness 
is crucial to improving cardio metabolic health and decreasing 
CVD risk in children [46]. In adults fitness is key to improving 
cardio metabolic health. 
Cultures apart
A neoliberal perspective of the NZ health system has seen a shift 
away from a governmental health responsibility towards one of 
individualised lifestyle accountability. Rather than investment 
in the prerequisites of good health, that of income, housing 
and nutrition, healthcare promotion policies are cloaked in the 
political ideology of neoliberalism, whereby the fundamentals 
of health, unemployment, poverty, lack of education, all 
important social determinants of health are largely ignored 
and seen as poor personal choices made by a population who 
are able to rectify such social and economic conditions [47]. 
Such social determinants of health, once seen as a failure of the 
state are now viewed as a personal failure requiring personal 
accountability [48]. Health promotion messages of; “Five plus 
a day,” “Be healthy, be active”; “Eat healthy and lose weight” 
are widely publicised throughout Western societies, are hailed 
as panacea to modern day health concerns and chronic disease 
[47]. However, as social and economic conditions worsen the 
burden of treating chronic disease on national health expenditure 
increases exponentially [49]. Unable to afford healthy lifestyle 
options Māori are frequently subjected to negative stereotypes 
and deficit explanations that unfairly direct fault at Māori for 
being obese, unhealthy, and sedentary along with accusations 
that they make poor lifestyle choices [48,50]. Accusations 
such as these ignore genetic, contemporary socio-cultural 
and environmental factors that contribute to their unhealthy 
lifestyle. The imposition of neoliberal personal responsibility 
Indicator Māori Non-Māori
Males Females Total Males Females Total
Total cardiovascular 
disease mortality
346.9
(328.6–365.9)  
232.3
(219.2–246.1)  
286.8
(275.7–298.3)
168.2
(165.3–171.0)   
99.2
(97.6–100.8)   
132.4
(130.8–133.9)
Total cardiovascular 
disease hospitalization
3725.6
(3660.3–3791.8)
2710.2
(2658.6–2762.6)
3186.4
(3145.3–3228.0)
2537.2
(2522.1–2552.3)
2552.3)
(1366.5–1385.7)
1938.6
(1926.9–1947.4)
Stroke mortality,
44.7
(38.3–51.9)
50.6
(44.5–57.3)
48.2
(43.7–53.0)
30.9
(29.8–32.1)
30.2
(29.3–31.0)
30.9
(30.2–31.6)
Stroke hospitalization
355.1
(335.3–375.8)  
374.2 
(355.4–393.6)  
365.7
(352.1–379.8)
245.1
(240.8–249.5)  
172.3
(169.2–175.4)  
207.6
(205.0–210.3)
Heart failure mortality, 5.4
(3.3–8.3)
4.9
(3.3–7.0)
5.2
(3.9–6.9)
2.2
(2.0–2.5)
2.2
(2.0–2.4)
2.2
(2.1–2.4)
Heart failure 
hospitalization
676.1
(648.7–704.3)  
434.8 
(414.3–456.0)  
547.5 
(530.6–564.7)
179.7 
(176.4–183.0)
96.8
(94.9–98.8)
1.0
(0.9–1.2)
Rheumatic heart disease 
mortality,
5.0
(3.6–6.9)
5.7
(4.3–7.5)
5.4
(4.4–6.7)
0.9
(0.7–1.1)
1.1
(1.0–1.3)
1.0
(0.9–1.2)
Rheumatic heart disease 
mortality,
27.6 
(3.6–6.9)
48.6
(43.4–54.1)
38.7
(35.4–42.2)
6.8
(6.2–7.4)
9.2
(8.5–9.9)
8.0
(7.6–8.5)
Notes:
1. Data from [45]
2. Rates are for individuals of 35+ years, per 100,000, between years 2010-2012
3. Figures are age-standardised to the total Māori population as recorded in the 2001 Census. Prioritised ethnicity has been used − 
see ‘Ngā tapuae me ngā raraunga: Methods and data sources’ for further information.
4. Sources: Mortality Collection Data Set (MORT), Ministry of Health; National Minimum Data Set (NMDS), Ministry of Health
Table 1: Cardiovascular disease indicators, by gender, Māori and non-Māori.
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neglects the complexity inherent in this issue and the barriers 
that influence choices available to Māori [48]. 
With the introduction of the “National Science Challenges” 
(NSC) aimed at restructuring national scientific research funding, 
Māori health research and researchers were rarely recognised. 
Such lack of recognition has led to cries of multicultural 
neoliberalism whereby the New Zealand government were 
purposefully failing to substantively include Māori input or 
perspectives forcing Māori to continually claim and defend 
space for indigenous research in New Zealand [51].
The concept of health may differ between cultural groups [46]. 
Although the Western idea of health is the absence of disease, 
the concept for Māori is somewhat different, as it includes 
spirit, family, mind, land and physical well-being (Figure 5). 
For Māori issues of Te Whenua (land), Te Reo (language) and 
Whanaungatanga (extended family) are central to their culture 
and health [46,10,11]. It is therefore a mistake to educate for a 
healthy lifestyle unless Māori are aware of the links between 
poor physical health and how this impacts on their spiritual, 
mental and family wellbeing.
This expanded model of 5 interconnected aspects of Māori 
health and wellbeing includes land as part of their worldview. 
Whenua [land] is seen as being centrally relevant to health 
and illness by Māori spiritual healers [52]. The holistic view 
includes land as it is seen as a fundamental part of the person’s 
existence and an inclusive part of Māori identity. Any strategy 
for the modification of lifestyle will therefore be limited unless 
it includes an holistic perspective of health suggests that western 
medicine often fails to acknowledge a Māori worldview, and as 
a result the power of self-determination for Māori is reduced 
[46,53]. However, they caution that Māori health practitioners 
must not assume that Māori patients or researchers want Māori 
specific content. This was evident in their study where Māori 
specific options were declined by most of the participants.
Cameron et al. screened rural and urban Māori (n=252, 243, 
respectively) with non-Māori (n=256) aged between 20-64 
years of age for CVD and associated risk factors. They found 
that rural Māori were at greatest risk of CVD because of higher 
levels of; obesity, dyslipidaemia, hypertension, smoking, type 2 
diabetes and hyperuricaemia, than urban Māori, and urban non-
Māori (Figure 6) [54]. A number of researchers have concluded 
that the development of an integrated healthcare programme is 
required to address the increased risks of CVD in rural and urban 
Māori that is sensitive to their cultural perspective of health [54-
56]. While interventions that focus upon such risk factors are 
important they will fail to fully address the ethnic inequities 
that exist in New Zealand healthcare unless the socioeconomic 
inequities such as poverty are addressed first [33]. A weakness 
of interventions developed to improve Māori cardiovascular 
health suggest lies in their aim to change Māori behaviour rather 
than the behaviour of society towards Māori. The fundamental 
causes of ethnic differences in healthcare are rooted in; culture, 
biology, racism, economic deprivation and the politics of the 
dominant culture [9,33].
Low levels of engagement with primary healthcare providers 
has been observed in elderly patients of ethnic minorities 
with chronic disease conditions [57]. Such poor engagement 
reinforces a sense of powerlessness in the very people who 
require the greatest support. They suggested that clinicians must 
 
Adapted from [46,52]
Figure 5: The interface of the pathophysiology of CVD and 
cultural awareness for Māori.
Data taken from Cameron et al. [54]. Obesity is age adjusted body mass index kg/m2
Figure 6: Risk factors of CVD for Pākehā, rural and urban Maori.
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be willing to be guided by their patients’ perceptions of need, 
not by their own assumptions of similarity and beliefs about 
illness and clinical management. As chronic conditions such as 
CVD are increasingly managed within the primary healthcare 
sector, Government policy must advocate greater engagement 
with vulnerable populations that emphasize health equity 
and provide incentives to general practitioners to adopt new 
approaches [58].
Using kaupapa Māori action research (“Māori Utilisation 
and Experience of Ischaemic Heart Disease Management”) 
to improve the health and well-being of Māori within the 
northern region of Aotearoa/New Zealand has presented new 
opportunities to work with Māori communities and utilise a more 
sensitive approach to raising awareness of Māori to the dangers 
of CVD [59]. The integration of kaupapa Māori concepts in 
health research, combining the best of Māori worldview and 
western medicine is a novel way forward for positive outcomes 
for Māori cardiovascular health [53].
Although the New Zealand guidelines for the assessment and 
management of CVD recommend that high risk patients, or 
those who have previously had a CVD event, should be offered 
antihypertensive, antiplatelet and lipid lowering therapies, (New 
Zealand Guidelines Group, 2003), only 67% of patients with 
diagnosed CVD were prescribed medications by their primary 
care physician [60]. In a 2012 study, only 60% of patients 
discharged from NZ hospitals with coronary heart disease were 
prescribed sufficient daily doses of statins. Amongst those at 
risk of CVD the prescription rates and long term adherence 
to preventive medications is much lower in Māori and Pacific 
Island ethnic groups [61]. The reasons for non-adherence 
have been indicated as; cost, regimen complexity, cultural 
beliefs regarding medication and; amongst patients with 
diabetes, depression [62]. One strategy designed to simplify the 
medication regimen is to combine the preventive medications 
in a ‘polypill’. In a 2011 randomised control trial (RCT) named 
Improving Adherence using Combination Therapy (IMPACT) 
Selak et al. assessed the use of a polypill, aimed at improving 
adherence amongst Māori and non-Māori patients at high 
risk of CVD in a New Zealand [61]. This study showed that 
the administration of a fixed dose combination drug treatment 
contains aspirin, statin, and two blood pressure lowering agents 
led to improved adherence and high acceptability to patients at 
risk of CVD, and their primary healthcare physicians. However, 
there was no statistical improvement in risk factors with the 
polypill when compared to the control group. The reason 
for this is likely to be that individual treatment modalities 
were already high in the control group, so improvement was 
relatively small [63]. The mean discontinuation rate for the 
fixed dose combination polypill treatment was 20% per year, a 
discontinuation rate similar to that reported by others [64-66].
Moving forward
In an effort to redress the imbalance in CVD between Māori and 
Pākehā Maori leaders in CV health suggested an action plan to 
improve health sector responsiveness to Māori The plan has six 
categories that reflect the need for a multi-level, multi-sector 
approach to improving cardiovascular outcomes [67]. 
1. Policy development- the need for prioritise Māori health 
to gain explicit recognition of the Treaty of Waitangi in 
all health policy directives.
2. Information systems- The need for complete and 
consistent collection of ethnicity data in order to monitor 
CVD inequalities.
3. Needs assessment- CVD needs assessments for Māori 
communities.
4. Quality standards- Strongly recommend Māori-specific 
and equity-based performance indicators are applied to 
the cardiac healthcare.
5. Workforce development- To recruit Māori cardiovascular 
health workers.
6. Research- Both quantitative and qualitative research 
pertaining to access and equity of healthcare for Māori 
with CVD is required.
Bramley suggest that any health policy that aims to achieve 
equity for Māori CVD must be encompass all six points. Sadly 
the recommendations of the group have had little impact on the 
inequity between Māori and Pākehā [67]. Indeed suggest that 
institutional racism inherent in the New Zealand health system 
may result in perpetuating inequity between Māori and Pākehā. 
In New Zealand there are few successful CVD prevention and 
treatment programmes aimed at Māori, however some established 
schemes include: a) The PREDICT-CVD an electronic medical 
record decision support system was implemented in the ProCare 
Primary Health Organisations (PHOs) in Auckland; b) One 
Heart, Many lives, has been established to increase awareness, 
assessments, and treatment of Māori, a social networking 
program targeting CVD in Māori males using methods of 
risk reduction that include lifestyle changes and cost-effective 
chronic medication; c) The Indigenous Health Framework 
(HIF), developed by the University of Otago, is comprised of 
the Hui process and the Meihana model and used in the medical 
interview to provide a clinical assessment framework [35]. This 
scheme aims to translate the principles of cultural competency 
into an everyday approach for use by health practitioners to 
improve health service delivery for Māori patients and their 
Whanau [68]. Themes common to many successful CVD 
prevention schemes for indigenous peoples include many 
of the points outlined by including: A dedicated focus on the 
indigenous population, widespread community involvement, 
often using of indigenous community health workers, a focus on 
individuals at a high-risk CVD and regularly contact between 
the program and participants [67].
Traditionally the medical management of acute conditions is 
characterised by an initial consultation with a primary health 
provider followed by patient compliance with a treatment 
regimen, a strategy that is evidently failing Māori. When 
managing chronic conditions such as CVD it is imperative that 
patients take more active role patients in the day-to-day decisions 
about the management of their illness [69]. To achieve ideal 
care health providers must interact with informed, empowered 
patients who are active in managing their own health [70-72]. 
In order to bridge the cultural divide between minority groups 
such as Māori and New Zealand’s Pākehā dominated western 
medicine and better manage chronic conditions such as CVD, 
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culturally appropriate nurses should be employed by DHB’s and 
attached to PHO’s as chronic care managers. The role of a care 
manager is to develop individualised care plans in collaboration 
with the patient and the care providers that optimize the patient's 
health status and quality of life [73-76]. A number of studies 
have demonstrated the effectiveness of such patient-provider 
collaborations, including the LEONARDO project, with its 
extension the NARDINO project and the studies of highlighted 
the necessity to standardise the role chronic care managers 
within primary care to improve the implementation of chronic 
disease management strategies [69,73]. In view of the success 
of schemes such as the LEONARDO project similar provisions 
should be undertaken to increase the management of CVD in 
New Zealand.
Conclusion
Biculturalism has challenged New Zealand society to confront 
racial inequity and its debate has promoted societal recognition 
of human rights [57]. New Zealand has struggled to put equity 
principles into practice, indicating will without enactment. 
Equity they suggest is not systematically addressed below 
strategic levels and that it does not shape funding decisions, 
program development, implementation and monitoring. Despite 
examples of exceptional practice, driven by individuals, there 
is little incentive to pursue equity in New Zealand. Variation 
in healthcare provision for minorities between District Health 
Boards (DHBs) and between Primary Health Organizations 
(PHOs) implies substantial regional inequity. New Zealand 
healthcare has a fractured system of individual authorities 
with little or no governmental policies to address healthcare 
inequity and develop synchronous policies across the many 
DHBs. Detailed planning and the implementation of healthcare 
policy was devolved to DHBs who often further devolved 
responsibility to PHOs [57]. Despite inequities being recognised 
in DHB strategic documentation they have not been addressed 
systematically below this level. 
In New Zealand, inequities in health are regarded as avoidable, 
unnecessary and unjust. The reduction of such inequities is one 
of the main objectives in the New Zealand Health Strategy. 
The Health Equity Assessment Tool (HEAT) was devised by 
the Ministry of Health in 2002 for the assessment of healthcare 
interventions to reduce inequities and guide the development of 
DHB strategies to address the potential of policies, programs 
and service interventions for reducing inequities [77]. However, 
in practice there has been little evidence that inequity has been 
addressed for Māori, Pacific peoples or Asian minorities, or 
for people on low-incomes or by geography [77]. Inequity in 
healthcare has been defined as a complex “wicked” problem. 
Wicked problems are difficult to clearly define; have many 
interdependencies and are often multi-causal; attempts to 
address them often lead to unforeseen consequences, they are 
often unstable, usually have no clear solution, are socially 
complex, hardly ever sit conveniently within the responsibility of 
a single organization, involve changing behaviour, and are often 
characterized by chronic policy failure [78]. Addressing such 
problems such as inequity in healthcare requires a governmental 
approach to construct and manage a collaboration of the many 
interested parties to develop policy for funding, monitoring and 
regulation, education and culture changes [79]. Government 
must realise that health in the community is also dependent 
upon other issues such as social welfare and housing. Because 
health inequities are insufficiently monitored, governments are 
poorly informed of their failure to address these issues that are a 
fundamental human right. 
If, as reported, social deprivation, abuse, neglect, household 
dysfunction and poverty remain risk factors for chronic 
disease in adulthood such as CVD then government policies 
must address this [80-85]. The right to health, for the state to 
provide the highest attainable standard of physical and mental 
health, is not an unreasonable expectation of citizens of the 
state [85]. The right to health is essential for alleviating poverty 
[86]. Moving people out of poverty requires much more than 
money [87]. If the New Zealand government is to address the 
inequities in healthcare it requires a greater commitment to a 
more redistributive social and economic agenda and to protect 
the most vulnerable members of society, our children, from 
developing chronic diseases in adulthood it is essential to reduce 
poverty [88]. Child welfare needs to be urgently addressed 
and children at risk of social deprivation, abuse, neglect and 
household dysfunction must be identified and supported e.g., 
with home visits from district health nurses and quality foster 
care.
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